openPR Logo
Press release

Biofertilizers Market to Reach USD 14.0 Billion by 2035, Growing at 10.8% CAGR | Novozymes, UPL, Valent BioSciences Among Key Players

05-29-2026 09:43 AM CET | Health & Medicine

Press release from: Roots Analysis

Biofertilizers Market to Reach USD 14.0 Billion by 2035, Growing

The global biofertilizers market, valued at USD 4.6 billion in 2024, will reach USD 5.0 billion in 2025 and expand to USD 14.0 billion by 2035, according to a newly published report by Roots Analysis. That trajectory represents a compound annual growth rate of 10.8% across the forecast period, making biofertilizers one of the fastest-scaling segments in the broader agricultural inputs industry. The combination of regulatory pressure on synthetic fertilizers, consumer-driven demand for organic produce, and rapid advances in microbial science is compressing what was once a slow-moving adoption curve into a decade-long sprint.

To explore the complete findings, request a free sample of the report at https://www.rootsanalysis.com/reports/biofertilizers-market/request-sample.html

Market Overview: Why Biofertilizers Are Moving From Niche to Mainstream
Biofertilizers are microbial or plant-extract-based preparations that supply nutrients to crops by fixing atmospheric nitrogen, solubilizing soil phosphorus, and stimulating root development. They address a specific and costly failure of conventional agriculture: the continued use of synthetic fertilizers has degraded soil physio-chemical properties at scale, reducing long-term yields even as input costs rise. Biofertilizers restore microbial activity to degraded soils while delivering measurable yield improvements, making them a functional substitute rather than simply a feel-good alternative.

The policy environment is accelerating adoption at a pace that market forces alone would not have achieved. The European Union's Farm to Fork strategy specifically targets a reduction in chemical and synthetic fertilizer use, requiring member states to replace a portion with biologically based alternatives. In the United States, Minnesota's Department of Agriculture launched its Biofertilizer Innovation and Efficiency Pilot Program in March 2026, offering farmers a USD 15 per acre incentive to cut commercial nitrogen fertilizer application by 15%. India's NITI Aayog constituted a Task Force in April 2026 to assess biofertilizer production capacity and recommend national strategies to boost supply. These are not fringe programs; they signal that governments on three continents are embedding biofertilizers into agricultural policy infrastructure.

Private capital is following. BioConsortia secured USD 15 million in August 2025 to accelerate the commercial launch of Always-N, a next-generation nitrogen-fixing biofertilizer using gene-edited microbes for industrial corn production. Meanwhile, Kimitec and Bayer jointly launched two advanced biological products in June 2025 targeting nutrient assimilation and stress resilience. The biofertilizers market holds approximately 30% of the wider agricultural biologicals market, and analysts expect that share to grow as product performance gaps close.

Key Growth Drivers
Regulatory Restrictions on Synthetic Fertilizers. Governments in North America, Europe, and Asia-Pacific are tightening limits on nitrogen and phosphorus inputs, citing soil degradation and water contamination. The EU Farm to Fork strategy and NITI Aayog's India initiative are creating demand floors that biofertilizer manufacturers can plan production capacity around, reducing the commercial risk that once discouraged large-scale investment.
Rising Consumer Demand for Organic and Sustainably Grown Food. Organic food sales have grown consistently across developed markets, and the supply chains serving those buyers require certified input standards at the farm level. Biofertilizer adoption is often a prerequisite for organic certification, creating a direct commercial link between consumer preference and farm-level purchasing decisions. This connection bypasses the need for farmer education and instead pulls demand through the retail value chain.

Advances in Microbial Technology and Formulation Science. Product quality in the biofertilizers segment has historically been inconsistent, limiting trust among commercial growers. Improvements in microbiome-based consortia formulations, which combine bacteria, fungi, and archaea for synergistic soil effects, are changing that calculus. Gene-edited microbial strains, such as those in BioConsortia's Always-N product, now fix nitrogen with reliability that approaches synthetic alternatives in controlled conditions.

Integration with Precision Agriculture and IoT Soil Sensing. Market participants are developing biofertilizer application systems that connect to IoT-based soil sensors, enabling real-time monitoring of moisture, temperature, and nutrient levels. Precision application reduces waste and improves efficacy, addressing the core concern about biofertilizer performance variability. This integration also aligns the product category with the digital agriculture investment wave, attracting capital that would not otherwise flow into biological inputs.

Regenerative Agriculture Adoption. Regenerative farming practices prioritize soil microbiome health, and biofertilizers are a primary tool for rebuilding microbial diversity in depleted soils. Peer-reviewed evidence suggests that biofertilizer integration within regenerative systems can reduce total fertilizer requirements by up to 20% across diverse farming ecosystems. As more large-scale commodity farmers explore regenerative transition, biofertilizer manufacturers are positioning products for that channel.

Market Segmentation: Foliar Sprays Lead, Seed Treatments Set to Accelerate
The biofertilizers market segments by source of product (microbes, plant extracts, and other sources), mode of application (foliar sprays, seed treatments, soil treatments, and other applications), and type of crop treated (cereals and pulses, fruits and nuts, green fodder, vegetables and tubers, oilseeds, industrial crops, textile crops, and other crops). By source, the microbes segment dominates, reflecting the commercial maturity of bacterial and fungal nitrogen fixation and phosphate solubilization technologies. By crop type, cereals and pulses hold the largest share in 2025, a function of their global cultivation footprint and the well-documented benefits of nitrogen-fixing rhizobia in legume production.

Foliar sprays capture approximately 55% of the market by mode of application, driven by their compatibility with lower input doses, faster nutrient absorption through leaf surfaces, and minimal soil interaction that makes performance more predictable. Seed treatments, while a smaller current share, will grow at a relatively higher CAGR through 2035. Their expansion is tied to documented improvements in germination rates and reduction in soil-borne disease incidence, attributes that appeal directly to high-value crop producers managing yield risk at the field level.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/biofertilizers-market/request-quote.html

Regional Insights: North America Leads, Asia-Pacific Grows Fastest
North America and Europe together account for approximately 60% of global biofertilizers market share in 2025, and their combined dominance will persist through the forecast period. In North America, state-level incentive programs, a mature organic food retail sector, and a large commercial agriculture base with the capital to trial new inputs are sustaining demand. In Europe, the Farm to Fork strategy has given biofertilizer adoption a regulatory mandate that supplements market incentives. Several major manufacturers have their primary operations in these two regions, and their proximity to well-funded research institutions accelerates product development cycles.

Asia-Pacific stands out as the fastest-growing region through 2035. Rising consumer demand for organic produce, urbanization-driven dietary shifts, and active government support for sustainable farming in India, China, and Southeast Asia are fueling that growth. The NITI Aayog task force in India specifically signals national-level commitment to scaling both production and consumption of biofertilizers. Asia-Pacific also hosts the highest concentration of biofertilizer manufacturers globally, a supply-side advantage that supports competitive pricing and broader smallholder adoption. Latin America and the Middle East and North Africa represent smaller shares today but offer long-term upside as regulatory frameworks for biological inputs mature.

Competitive Landscape
Key players identified in the report include AMVAC, Certis Biologicals, Valent BioSciences, Grow Indigo, Novozymes, Nutri-Tech Solutions, ProFarm, Stoller, UPL, and Verdesian Life Sciences, among others profiled in the full research.
The biofertilizers market features a mix of large agrochemical groups with biological divisions, specialist biologicals firms, and well-funded startups deploying gene-editing and synthetic biology platforms. The main competitive battleground is efficacy consistency; manufacturers that can demonstrate reliable yield outcomes across variable soil and climate conditions command premium pricing and secure long-term supply agreements with large grower cooperatives. IP around novel microbial strains and consortia formulations is emerging as a strategic moat, and several players are pursuing partnerships with universities and government research programs to build proprietary pipelines. Geographic expansion into Asia-Pacific, where the demand growth curve is steepest, is a secondary focus for established North American and European players.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/biofertilizers-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biofertilizers Market to Reach USD 14.0 Billion by 2035, Growing at 10.8% CAGR | Novozymes, UPL, Valent BioSciences Among Key Players here

News-ID: 4531090 • Views:

More Releases from Roots Analysis

Vaccine Adjuvants Market to Reach USD 6.08 Billion by 2035 | Adjuvance Technologies, Avanti Polar Lipids, Blue Willow Biologics Among Key Players
Vaccine Adjuvants Market to Reach USD 6.08 Billion by 2035 | Adjuvance Technolog …
The global vaccine adjuvants market, valued at USD 5.26 billion in 2025, will reach USD 5.51 billion in 2026 and USD 6.08 billion by 2035, advancing at a compound annual growth rate (CAGR) of 1.1% over the forecast period 2026 to 2035, according to a new market intelligence report published by Roots Analysis. The steady expansion reflects accelerating demand for more immunologically sophisticated vaccine formulations, the proliferation of sub-unit and
Wearable Injectors Market to Reach USD 13.0 Billion by 2035 at 7.4% CAGR | Becton Dickinson, Insulet, Tandem Diabetes Care
Wearable Injectors Market to Reach USD 13.0 Billion by 2035 at 7.4% CAGR | Becto …
The global wearable injectors market, valued at USD 6.5 billion in 2025, will grow to USD 6.8 billion in 2026 and reach USD 13.0 billion by 2035, advancing at a compound annual growth rate of 7.4% through the forecast period. This near-doubling in market value reflects accelerating demand for home-based drug delivery systems, particularly for the management of chronic diseases including diabetes, cancer, and autoimmune disorders across both developed and
Single Use Bioreactors Market to Reach $10.48 Billion by 2035, Growing at 9.03% CAGR | Sartorius AG, Thermo Fisher Scientific, Cytiva
Single Use Bioreactors Market to Reach $10.48 Billion by 2035, Growing at 9.03% …
The global single use bioreactors market, valued at USD 4.32 billion in 2025, will grow to USD 4.81 billion in 2026 and reach USD 10.48 billion by 2035, advancing at a CAGR of 9.03% over the forecast period. That trajectory reflects a fundamental shift in how the biopharmaceutical industry produces biologics, as manufacturers trade capital-heavy stainless-steel infrastructure for flexible, disposable systems that cut costs by roughly 40% and reduce energy
Quantum Computing in Drug Discovery Market to Reach USD 1,692 Million by 2035, Growing at 18.7% CAGR | IBM, IonQ, Microsoft Among Key Players
Quantum Computing in Drug Discovery Market to Reach USD 1,692 Million by 2035, G …
The global quantum computing in drug discovery market, valued at USD 315 million in 2025, will reach USD 361 million in 2026 and is on track to hit USD 1,692 million by 2035, advancing at a compound annual growth rate of 18.7% over the forecast period 2026 to 2035. The convergence of quantum hardware advancement, AI-assisted molecular modeling, and surging demand for faster, more precise drug development pipelines is accelerating

All 5 Releases


More Releases for USD

Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery? The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care. In 2025, the global bone cement market was valued at
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine? The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness. In 2025, the global autologous cell therapy
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75B
How Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population? The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare Introduction: PACS at the Core of Modern Medical Imaging The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making Introduction: The Growing Importance of HEOR in Modern Healthcare The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in